Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 27, Issue 3, 2011, Pages 483-490

  Mosconi, Lisa ^a   De Leon, Mony ^a,c   Murray, John ^a   E, Lezi ^b   Lu, Jianghua ^b   Javier, Elizabeth ^a   McHugh, Pauline ^a   Swerdlow, Russell H ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Early diagnosis; electron transport complex IV; late onset Alzheimer's disease; mitochondria

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; EARLY DIAGNOSIS; ELECTRON TRANSPORT; ENZYME ACTIVITY; FAMILY HISTORY; FEMALE; HUMAN; LATE ONSET ALZHEIMER DISEASE; MALE; MINI MENTAL STATE EXAMINATION; MITOCHONDRION; MOTHER; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; THROMBOCYTE;

EID: 80055088009     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110866     Document Type: Article

References (40)

1. Farrer LA, O'Sullivan DM, Cupples AC, Growdon JH, Myers RH(1989) Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol 25, 485-493. (Pubitemid 19136680)
2. Blacker D, Tanzi RE (1998) The genetics of Alzheimer disease. Arch Neurol 55, 294-296.
3. Mosconi L, Brys M, Switalski R, Mistur R, Glodzik-Sobanska L, Pirraglia E, Tsui WH, De Santi S, e Leon MJ (2007) Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A 104, 19067-19072.
4. Mosconi L, Mistur R, Glodzik L, Brys M, Switalski R, Pirraglia E, Rich K, Tsui W, De Santi S, de Leon MJ (2009) Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer's. Neurology 72, 513-520.
5. Mosconi L, Rinne JO, TsuiW, Berti V, Li Y, Murray J,Wang H, Scheinin N, Nagren K, Williams S, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ (2010) Increased fibrillar amyloid- burden in normal individuals with a family history of late-onset Alzheimer's disease. Proc Natl Acad Sci U S A 107, 5949-5954.
6. Mosconi L, Glodzik L, Mistur R, McHugh P, Rich K, Javier E,Williams S, Pirraglia E, De Santi S, Mehta P, Zinkowski R, Blennow K, Pratico D, de Leon MJ (2010) Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's. Biol Psychiatry 68, 913-921.
7. Honea RA, Swerdlow RH, Vidoni E, Goodwin J, Burns JM (2009) Reduced Gray Matter Volume in Normal Adults with a Maternal Family History of Alzheimer Disease. Neurology 74, 113-120.
8. Honea RA, Swerdlow RH, Vidoni ED, Burns JM (2011) Progressive regional atrophy in normal adults with a maternal history of Alzheimer's disease. Neurology 76, 822-829.
9. Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon MJ(2010) Maternal transmission of Alzheimer's disease: Prodromal metabolic phenotype and the search for genes. Human Genomics 4, 170-193.
10. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. (Pubitemid 44622683)
11. Swerdlow RH, Kish SJ (2002) Mitochondria in Alzheimer's disease. Int Rev Neurobiol 53, 341-385
12. Wong-Riley MTT (1989) Cytochrome oxidase: An endogenous metabolic marker for neuronal activity. Trends Neurosci 12, 94-101. (Pubitemid 19067056)
13. Cardoso SM, Proenca MT, Santos S, de Oliveira CR (2004) Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 25, 105-110. (Pubitemid 37522198)
14. Parker WD, Jr, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40, 1302-1303. (Pubitemid 20244999)
15. Parker WD, Jr, Mahr NJ, Filley CM, Parks JK, Hughes D, Young DA, Cullum CM (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44, 1086-1090. (Pubitemid 24188183)
16. Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, Murri L, Rapoport SI, Solaini G (2002) Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 23, 371-376. (Pubitemid 34312019)
17. Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36, 747-750.
18. Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 63, 2179-2184. (Pubitemid 24369993)
19. Valla J, Schneider L, Niedzielko T, Coon KD, Caselli RJ, Sabbagh MN, Ahern GL, Baxter L, Alexander GE, Walker DG, Reiman EM (2006) Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 6, 323-330. (Pubitemid 44817367)
20. Valla J, Berndt JD, Gonzales-Lima F (2001) Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: Superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 21, 4923-4930. (Pubitemid 32565651)
21. Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AH (1992) Platelet mitochondrial function in Parkinson's disease, The Royal Kings and Queens Parkinson Disease Research Group. Ann Neurol 32, 782-788.
22. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, Morris JC (1996) Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance. Neurology 47, 254-256. (Pubitemid 26243893)
23. 23] Gomez-Tortosa E, Barquero MS, Baron M, Sainz MJ, Manzano S, Payno M, Ros R, Almaraz C, Gomez-Garre P, Jimenez-EscrigA(2007)Variability of age at onset in siblings with familial Alzheimer disease. Arch Neurol 64, 1743-1748. (Pubitemid 350254936)
24. Debette S, Wolf PA, Beiser A, Au R, Himali JJ, Pikula A, Auerbach S, DeCarli C, Seshadri S (2009) Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology 73, 2071-2078.
25. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Bio l8 101-112. (Pubitemid 46432529)
26. Glabe CG, KayedR(2006) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66, S74-S78. (Pubitemid 43739989)
27. Swerdlow RH, Khan SM (2009) The Alzheimer's disease mitochondrial cascade hypothesis: An update. Exp Neurol 218, 308-315.
28. Reddy PH, McWeeny S, Park BS, Manczak M, Gutala RV, Partovi D, Jung Y, Yau V, Searles R, Mori M, Quinn J (2004) Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Molec Genet 13, 1225-1240. (Pubitemid 38877876)
29. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 106, 14670-14675.
30. SwerdlowRH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP, Jr, Davis RE, Parker WD, Jr (1997) Cybrids in Alzheimer's disease: A cellular model of the disease? Neurology 49, 918-925. (Pubitemid 27456066)
31. Khan SM, Cassarino DS, Abramova NN, Keeney PM, Borland MK, Trimmer PA, Krebs CT, Bennett JC, Parks JK, Swerdlow RH, Parker WD, Jr, Bennett JP, Jr (2000) Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol 48, 148-155. (Pubitemid 30617032)
32. Cardoso SM, Santana I, Swerdlow RH, Oliveira CR (2004) Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J Neurochem 89, 1417-1426. (Pubitemid 38802663)
33. Parker WD, Jr., Parks JK (1995) Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization. Neurology 45, 482-486.
34. Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankuer BA (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269, 13623-13628. (Pubitemid 24206141)
35. Pratico D, Uryu K, Leight S, Trojanowski JQ, Lee VMY (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21, 4183-4187. (Pubitemid 32538543)
36. Coskun PE, Beal MF,Wallace DC (2004) Alzheimer's brains harbor somatic mtDNAcontrolregion mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A 101, 10726-10731. (Pubitemid 38955810)
37. Wallace DC (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628-632.
38. Lu J, Wang K, Rodova M, Esteves R, Berry D, E L, Crafter A, Barrett M, Cardoso SM, Onyango I, Parker WD, Fontes J, Burns JM, Swerdlow RH (2010) Polymorphic variation in cytochrome oxidase subunit genes. J Alzheimers Dis 21, 141-154.
39. Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM (2010) Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE e4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis 22, 307-313.
40. Kawas C, Segal J, Stewart WF, Corrada M, Thal LJ (1994) A validation study of the Dementia Questionnaire. Arch Neurol 51, 901-906. (Pubitemid 24286045)